MarketsandMarkets

PathDx 2023

23rd-24th March 2023

ILEC Conference Centre & Ibis London Earls Court, London

EVENT OVERVIEW

MarketsandMarkets is here with a platform for Scientists, Microbiologists, Biologists, Pathologists and Researchers to come together at the PathDx 2023 Confex on 23rd – 24th March 2023 in London. An opportunity to discuss future insights, innovations and research ideas with advanced solutions to the most challenges in infectious disease diagnostics, molecular diagnostics and digital pathologies verticals.

Witness 30+ presentations ranging over the upcoming advances and applications of Infectious Disease Diagnostics, Molecular Diagnostics and Digital Pathology.

Get a wind of how AI and machine learning are now applied to all the necessary diagnoses and clinical research. Be a part of interactive discussions on slide-free imaging, enterprise-wide solutions, and algorithms using machine learning and artificial intelligence that are being developed to improve diagnoses, guide treatment, and address a wide range of medical challenges.

Glimpse the panorama of some outstanding minds in the areas of Medical, Pharmaceutical, Biopharmaceutical and many other solution providers - all under the same roof. The event will also have interactive breakout sessions with 10+hours of dedicated networking.

The two conferences which are going to be a part of PathDx Confex 2023 are the 4th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference and MarketsandMarkets Next-Gen Digital Pathology Conference.

CO-LOCATED CONFERENCES

4th Annual Infectious Disease and Molecular Diagnostics Conference
MarketsandMarkets Next-Gen Digital Pathology Conference

WHAT TO EXPECT

  • Molecular Diagnostics in Oncology Challenges/Opportunities in Clinical Virology: Will Molecular Diagnostics Make Viral Diagnosis Better?
  • COVID from different perspectives
  • A systematic approach to novel virus through infectious disease diagnostics
  • Molecular Diagnostics in Infectious Diseases
  • Understanding and integrating computational pathology & Cloud computing in Digital Pathology
  • Critical role of digital pathology and AI in clinical decision making
  • Examining the latest developments in imaging technologies
  • Application of digital pathology in drug discovery

  • Learn about innovative devices and procedures for effective diagnostics
  • Meet global heads of infectious disease and molecular diagnostics from the industry and Academics
  • Resolve common R&D challenges
  • Participate in discussions with experts on how technology implementation can be improved
  • Recognize what digital pathology is and how it can be used in the practice of pathology
  • Attracting and retaining world-class pharma and biotech talent
  • Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods
  • Discuss the challenges associated with interfacing a digital pathology system
  • Interactive panel discussions
  • 120+ Professionals Attending

  • Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics
  • Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
  • Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators
  • Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
  • Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians
  • Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by